Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07775638 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07775638 · ClinicalTrials.gov record · last posted 2026-08-20

Detecting Liver Fibrosis in Patients At-risk

Study acronym: STELIR
StatusNot Yet Recruiting
PhaseNot specified
Started2026-08
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The project will establish a research cohort (called STELIR; STEatotisk Liver-risk In Rogaland) based on a biobank with an associated health register. The purpose is to collect, store and analyze biological material and clinical data from people at risk of steatotic liver disease (fatty liver disease). The research cohort will consist of individuals who agree to participate and will be followed over many years with planned examinations/tests at baseline, after 2 years, after 5 years and every 5 years thereafter. The STELIR cohort consists of individuals between 40 and 70 years of age who have one or more of the following risk factors: Obesity, type 2 diabetes or hazardous or harmful alcohol consumption. The biological material and clinical data collected will be stored and used for research on liver-related disease risk, diagnostics and treatment.
Trial Details
NCT Number NCT07775638
Lead Sponsor Helse Stavanger HF
Conditions Fatty Liver, NAFLD - Non-Alcoholic Fatty Liver Disease, Nash, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), Biomarker in Early Diagnosis, Liver Disease (Alcoholic or Not), Cirrhoses, Liver
Enrollment 1,200 participants
Start Date 2026-08
Primary Completion 2070-12-31 (estimated)
Study Completion 2070-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-20